Nao Yamakawa Selected Research

9-O-acetyl-N-acetylneuraminic acid

1/2019

Identification of 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac2) as main O-acetylated sialic acid species of GD2 in breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nao Yamakawa Research Topics

Disease

3	Neoplasms (Cancer) 12/2022 - 01/2019
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 11/2013
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
2	Neuroblastoma 01/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2019
1	Kidney Diseases (Kidney Disease) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Infections 01/2018
1	Malaria 11/2017
1	Bacterial Infections (Bacterial Infection) 07/2017
1	Pathologic Processes 01/2017
1	Cystitis 04/2014

Drug/Important Bio-Agent (IBA)

2	EpitopesIBA 01/2022 - 01/2018
2	GangliosidesIBA 01/2020 - 01/2019
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2019 - 01/2017
2	Mannose (D-Mannose)IBA 01/2018 - 04/2014
1	UromodulinIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	LectinsIBA 01/2022
1	9-O-acetyl-N-acetylneuraminic acidIBA 01/2019
1	sialogangliosidesIBA 01/2019
1	ProteomeIBA 11/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2017
1	Polysaccharides (Glycans)IBA 01/2017
1	Lactose FDA LinkGeneric 04/2014
1	AcetylglucosamineIBA 04/2014
1	Proteins (Proteins, Gene)FDA Link 11/2013

Therapy/Procedure

1	Radiotherapy 12/2022
1	Therapeutics 07/2017